Fumio Nakamura Selected Research

levodopa receptor

2/2022

Right ventricular overloading is attenuated in monocrotaline-induced pulmonary hypertension model rats with a disrupted Gpr143 gene, the gene that encodes the 3,4-l-dihydroxyphenyalanine (l-DOPA) receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fumio Nakamura Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 11/2011
4	Ocular Albinism 11/2019 - 01/2014
3	Alzheimer Disease (Alzheimer's Disease) 12/2019 - 02/2005
3	Neoplasm Metastasis (Metastasis) 07/2016 - 11/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 07/2016 - 11/2011
3	Pruritus (Itching) 09/2012 - 12/2008
2	Schizophrenia (Dementia Praecox) 01/2021 - 10/2016
2	Parkinson Disease (Parkinson's Disease) 11/2019 - 01/2014
1	Pulmonary Hypertension 02/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2019
1	Memory Disorders (Memory Loss) 12/2019
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Chronic Pancreatitis 07/2016
1	Pancreatitis 07/2016
1	Obesity 01/2015
1	Fibrosis (Cirrhosis) 01/2015
1	Hyperplasia 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 11/2014
1	Lung Neoplasms (Lung Cancer) 11/2014
1	Breast Neoplasms (Breast Cancer) 11/2014
1	Hypotension (Low Blood Pressure) 01/2014
1	Syncope (Fainting) 01/2014
1	Inflammation (Inflammations) 01/2013
1	Animal Disease Models 09/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2012
1	Adenocarcinoma 11/2011
1	Lymphatic Metastasis 11/2011
1	Sneezing 01/2011
1	Hypersensitivity (Allergy) 01/2011
1	Allergic Rhinitis 01/2011
1	Ganglion Cysts (Ganglion) 07/2009
1	Atopic Dermatitis (Atopic Eczema) 12/2008
1	Skin Diseases (Skin Disease) 12/2008

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2013
7	Semaphorin-3AIBA 07/2016 - 12/2008
3	Dihydroxyphenylalanine (Dopa)IBA 03/2015 - 01/2014
3	Messenger RNA (mRNA)IBA 11/2014 - 09/2012
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2011
2	Dopamine (Intropin)FDA LinkGeneric 11/2019 - 01/2014
2	Levodopa (L Dopa)FDA LinkGeneric 11/2019 - 01/2014
2	Retinaldehyde (Retinal)IBA 11/2014 - 07/2009
2	Semaphorins (Semaphorin)IBA 09/2012 - 11/2011
1	MonocrotalineIBA 02/2022
1	levodopa receptorIBA 02/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2022
1	Amyloid beta-PeptidesIBA 12/2019
1	ProteomeIBA 12/2019
1	Amino Acids FDA Link 11/2019
1	LithiumIBA 01/2017
1	Methamphetamine (Desoxyn)FDA LinkGeneric 10/2016
1	CeruletideIBA 07/2016
1	Phosphates (Orthophosphate)IBA 01/2016
1	Tyrosine (L-Tyrosine)FDA Link 01/2016
1	Phenylalanine (L-Phenylalanine)FDA Link 03/2015
1	perlecanIBA 01/2015
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2014
1	Small Interfering RNA (siRNA)IBA 12/2013
1	Amyloid (Amyloid Fibrils)IBA 11/2013
1	Nerve Growth Factor (NGF)IBA 09/2012
1	CollagenIBA 05/2012
1	AcetoneIBA 05/2012
1	Cytidine Triphosphate (CTP)IBA 05/2012
1	CD100 antigenIBA 11/2011
1	LigandsIBA 11/2011
1	Histamine Antagonists (Antihistamines)IBA 12/2008
1	SteroidsIBA 12/2008
1	Glycogen Synthase Kinase 3 betaIBA 02/2005

Therapy/Procedure

1	Therapeutics 01/2014
1	Oral Administration 05/2012
1	Intranasal Administration 01/2011